Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 3, 2006, Pages 309-313

  Agarwal, Rajiv ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Ambulatory blood pressure monitoring; Cardiovascular disease; Chronic kidney disease; Home blood pressure monitoring; Hypertension

Indexed keywords

AMBULATORY CARE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HOME MONITORING; HUMAN; HYPERTENSION; KIDNEY INJURY; MASKED HYPERTENSION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDARD; WHITE COAT HYPERTENSION;

BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; HUMANS; HYPERTENSION; KIDNEY DISEASES; PROGNOSIS; RENAL DIALYSIS;

EID: 33646796687     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000222700.14960.18     Document Type: Review

References (23)

1. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
2. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
3. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334:13-18.
4. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001; 161:1207-1216.
5. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249:2792-2798.
6. Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997; 15:357-364.
7. Ohkubo T, Hozawa A, Nagai K, et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000; 18:847-854.
8. Kikuya M, Ohkubo T, Asayama K, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45:240-245. This study emphasizes the importance of long-term follow-up of patients. With shorter follow-up of 5 years, a U-shaped relationship between ambulatory systolic blood pressure and survival was seen in this community-based study of people with essential hypertension. With 11 year follow-up, a J-shaped relationship was seen. Nighttime blood pressure was a stronger marker of outcomes than daytime blood pressure.
9. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348:2407-2415.
10. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156-161. This study of patients with essential hypertension referred from a specialized center showed that ambulatory blood pressure was a better predictor of mortality than clinic blood pressure.
11. Redon J, Campos C, Narciso ML, et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998; 31:712-718.
12. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999; 282:539-546.
13. Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis 2005; 45:994-1001.
14. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98:1892-1897.
15. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988; ii:397.
16. Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183-2189.
17. Verdecchia P, Schillaci G, Borgioni C, et al. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32:983-988.
18. Verdecchia P, Angeli F. How can we use the results of ambulatory blood pressure monitoring in clinical practice? Hypertension 2005; 46:25-26.
19. Agarwal R, Andersen MJ. Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension 2005; 46:514-520. This is the first study in patients with CKD that demonstrates a stronger relationship of out-of-clinic compared with clinic blood pressure measurements with kidney injury.
20. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
21. Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. kidney int 2006; 69 (2):406-411.
22. Amar J, Vernier I, Rossignol E, et al. Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney Int 2000; 57:2485-2491.
23. Tripepi G, Fagugli RM, Dattolo P, et al. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. Kidney Int 2005; 68:1294-1302. First study is evaluate in a large ESRD cohort the value of ambulatory BP monitoring hard outcomes.